
Catch up on insights into the global development of breast cancer treatments in the global spotlight.
Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses unmet needs in metastatic breast cancer.
Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses unmet needs in metastatic breast cancer.
This remains an incurable disease, Sparano says, although there have been significant improvements in clinical outcomes over the last few years. For patients with estrogen receptor-positive, HER2-negative disease, the rise of CDK4/6 inhibitors has dramatically changed the management of that setting. These agents haven





